Scarica l'app Stockscreener
23.19
0.04%
0.01
Precedente Chiudi:
$23.18
Aprire:
$23.4
Volume 24 ore:
558.64K
Relative Volume:
0.77
Capitalizzazione di mercato:
$754.96M
Reddito:
$796.33M
Utile/perdita netta:
$74.95M
Rapporto P/E:
11.35
EPS:
2.0427
Flusso di cassa netto:
$329.83M
1 W Prestazione:
+4.98%
1M Prestazione:
+4.51%
6M Prestazione:
-29.81%
1 anno Prestazione:
-30.17%
Intervallo 1D:
$22.86
$23.41
Intervallo di 1 settimana:
$21.46
$24.04
Portata 52W:
$21.43
$50.79
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
Nome
Collegium Pharmaceutical Inc
Settore
Telefono
781-713-3699
Indirizzo
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
Compare COLL vs TAK, TEVA, HLN, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
COLL
Collegium Pharmaceutical Inc
|
23.19 | 754.96M | 796.33M | 74.95M | 329.83M | 2.0427 |
TAK
Takeda Pharmaceutical Co Adr
|
19.67 | 62.84B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
41.50 | 48.40B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
10.13 | 44.55B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
79.38 | 32.80B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
533.12 | 22.87B | 3.17B | 1.29B | 1.01B | 27.09 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-09-23 | Iniziato | Oppenheimer | Outperform |
| 2026-09-09 | Iniziato | Leerink Partners | Outperform |
| 2026-09-09 | Ripresa | Truist | Buy |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-01-10 | Aggiornamento | Needham | Hold → Buy |
| 2024-07-30 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2024-06-07 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-05-10 | Downgrade | Needham | Buy → Hold |
| 2024-05-10 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-01-04 | Downgrade | Jefferies | Buy → Hold |
| 2023-08-25 | Reiterato | Needham | Buy |
| 2023-05-02 | Ripresa | Jefferies | Buy |
| 2022-08-08 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2022-02-15 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2021-08-06 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-01-11 | Reiterato | H.C. Wainwright | Buy |
| 2020-07-14 | Iniziato | BWS Financial | Sell |
| 2020-05-27 | Iniziato | Guggenheim | Neutral |
| 2020-02-19 | Ripresa | Jefferies | Buy |
| 2019-10-30 | Reiterato | Needham | Buy |
| 2019-05-03 | Ripresa | H.C. Wainwright | Buy |
| 2019-04-12 | Ripresa | Janney | Buy |
| 2019-03-20 | Iniziato | SunTrust | Hold |
| 2019-01-16 | Reiterato | Needham | Buy |
| 2018-03-08 | Reiterato | H.C. Wainwright | Buy |
| 2018-02-07 | Reiterato | Needham | Buy |
| 2017-12-05 | Reiterato | Needham | Buy |
| 2017-09-11 | Iniziato | H.C. Wainwright | Buy |
| 2017-05-11 | Reiterato | Needham | Buy |
| 2016-09-13 | Iniziato | Gabelli & Co | Buy |
| 2015-06-01 | Iniziato | Jefferies | Buy |
| 2015-06-01 | Iniziato | Needham | Buy |
| 2015-06-01 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Collegium Pharmaceutical Inc Borsa (COLL) Ultime notizie
Does Collegium Pharmaceutical (COLL) Have the Potential to Rally 111.39% as Wall Street Analysts Expect? - Zacks Investment Research
Amneal Pharmaceuticals, Inc. (AMRX) stock price, news, quote and history - Yahoo Finance Singapore
Four investors report shared voting power over Collegium Pharma (COLL) shares. - Stock Titan
New Strong Sell Stocks for October 7th - Zacks Investment Research
An estimated 15.5 million U.S. adults have ADHD. Three guides help families navigate care and school. - Stock Titan
Oppenheimer sets USD 50.00 target for Collegium Pharmaceutical stock - AD HOC NEWS
Amphastar Pharmaceuticals, Inc. (AMPH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Former officer Scott Dreyer proposes selling 27,419 Collegium Pharmaceutical (COLL) shares. - Stock Titan
Amylyx Pharmaceuticals, Inc. (AMLX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Amylyx Pharmaceuticals, Inc. (AMLX) stock price, news, quote and history - Yahoo Finance Australia
Oppenheimer initiates Collegium Pharmaceutical stock at Outperform - Investing.com
Leerink Partners Initiates Collegium Pharmaceutical(COLL.US) With Buy Rating, Announces Target Price $45 - Moomoo
COSCIENS ACQUIRES NUALTIS CORP. - The Manila Times
(COLL) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Collegium to Participate in Upcoming Investor Conferences - GlobeNewswire
Collegium Pharmaceutical stock edges higher after recent quarterly update - ad-hoc-news.de
Collegium Pharmaceutical Inc. (COLL) Peer Comparison – Compare with Others - Value Research
(COLL) Risk Channels and Responsive Allocation - Stock Traders Daily
A Look at Collegium Pharmaceutical Inc (COLL) After 3.9% Decline -- GF Value $47.17 vs Price $26.39 - GuruFocus
Israel A. Englander reports new Collegium (NASDAQ: COLL) stake - Stock Titan
Collegium (COLL) Move: Ends Higher by 2.18% at $27.70 in Latest Trading; Technical View: the $26.31 to $29.09 Range Remains in Focus in the Latest SessionETF NAV Deviation - vinanet.vn
Barclays Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Cuts Target Price to $48 - Moomoo
5 Revealing Analyst Questions From Collegium Pharmaceutical’s Q2 Earnings Call - Yahoo Finance
Fuller & Thaler (NASDAQ: COLL) reports 5.03% beneficial stake in common stock - Stock Titan
COLLEGIUM PHARMACEUTICAL INC : NEEDHAM CUTS TARGET PRICE TO $46 FROM $56 - webull.com
Can Collegium Pharmaceutical (NASDAQ:COLL) Rebound From Its Yearly Low? - Kalkine Media
Collegium Pharmaceutical Initiates $50 Million Accelerated Share Buyback with Jefferies LLC - Kalkine Media
Collegium Pharmaceutical stock jumps on $50M share buyback By Investing.com - Investing.com Canada
Collegium Pharmaceutical stock jumps on $50M share buyback By Investing.com - Investing.com India
Collegium Pharmaceutical stock jumps on $50M share buyback By Investing.com - Investing.com Nigeria
Collegium Pharmaceutical stock jumps on $50M share buyback By Investing.com - Investing.com South Africa
Why is Collegium Pharmaceutical stock climbing today? By Investing.com - Investing.com Canada
Why is Collegium Pharmaceutical stock climbing today? By Investing.com - Investing.com UK
Collegium Pharmaceutical stock jumps on $50M share buyback By Investing.com - Investing.com Australia
Collegium Pharmaceutical stock jumps on $50M share buyback By Investing.com - Investing.com Australia
Collegium Pharmaceutical stock jumps on $50M share buyback - Investing.com
Collegium Pharmaceutical stock jumps on $50M share buyback - Investing.com
Collegium Pharmaceutical Launches $50 Million Accelerated Share Repurchase Program - citybiz
Collegium Pharmaceutical to repurchase $50 million in stock By Investing.com - Investing.com Nigeria
Collegium Pharmaceutical to repurchase $50 million in stock By Investing.com - Investing.com South Africa
Collegium Pharmaceutical to repurchase $50 million in stock By Investing.com - Investing.com Australia
Collegium Pharmaceutical to repurchase $50 million in stock By Investing.com - Investing.com India
Collegium gains on accelerated share buybacks (COLL:NASDAQ) - Seeking Alpha
Collegium Pharmaceutical to repurchase $50 million in stock - Investing.com
Collegium Pharmaceutical to repurchase $50 million in stock By Investing.com - Investing.com Canada
Collegium Pharmaceutical to repurchase $50 million in stock By Investing.com - Investing.com UK
Collegium Pharmaceutical launches $50M accelerated share repurchase under $150M buyback program - TradingView
Collegium Announces $50 Million Accelerated Share Repurchase Program - GlobeNewswire
Collegium Pharmaceutical (NASDAQ:COLL) Sets New 1-Year LowTime to Sell? - MarketBeat
Collegium Announces $50 Million Accelerated Share Repurchase Program - finance.yahoo.com
Collegium Pharmaceutical Inc Azioni (COLL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Collegium Pharmaceutical Inc Azioni (COLL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Fallon John A. | Former Director |
Jul 17 '26 |
Proposed Sale |
35.73 |
13,920 |
497,429 |
0 |
| Fallon John A. | Former Director |
Jul 15 '26 |
Proposed Sale |
36.32 |
8,095 |
294,010 |
0 |
| SANTINI GINO | Director |
Jun 08 '26 |
Option Exercise |
16.49 |
8,700 |
143,463 |
112,483 |
| Freund John Gordon | Director |
May 18 '26 |
Proposed Sale |
34.05 |
30 |
1,022 |
0 |
| Freund John Gordon | Director |
May 18 '26 |
Sale |
34.05 |
20 |
681 |
83,952 |
| Freund John Gordon | Director |
May 15 '26 |
Sale |
34.54 |
4,127 |
142,547 |
83,972 |
| Freund John Gordon | Director |
May 15 '26 |
Proposed Sale |
34.54 |
4,127 |
142,547 |
0 |
| Freund John Gordon | Director |
May 15 '26 |
Option Exercise |
16.49 |
8,700 |
143,463 |
88,099 |
| Lurker Nancy | Director |
May 13 '26 |
Sale |
35.97 |
4,500 |
161,861 |
18,017 |
| Lurker Nancy | Director |
May 13 '26 |
Proposed Sale |
35.97 |
4,500 |
161,861 |
0 |
7.16%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):